Nasal steroids provided the most significant benefit, especially when compared to montelukast. Nasal antihistamines also ...
Exposure to irritants has been shown to increase nasal symptoms and cause exacerbations ... scale (VAS): VAS less than 3 (mild: intranasal corticosteroids); VAS above 3–10 (moderate to severe ...
GlobalData on MSN25d
China’s NMPA approves GSK’s Nucala for CRSwNP treatmentThe China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with intranasal corticosteroids to treat chronic rhinosinusitis with nasal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback